ID: ALA4845873

Max Phase: Preclinical

Molecular Formula: C47H61ClN10O7S

Molecular Weight: 945.59

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1OCC2(CCN(c3cnc(Sc4cccc(NC(=O)CCC(=O)NCCCCCCCCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)c4Cl)c(N)n3)CC2)[C@@H]1N

Standard InChI:  InChI=1S/C47H61ClN10O7S/c1-29-41(49)47(28-65-29)21-25-57(26-22-47)35-27-53-44(42(50)55-35)66-34-16-12-15-32(40(34)48)54-37(60)20-19-36(59)52-24-10-8-6-4-2-3-5-7-9-23-51-31-14-11-13-30-39(31)46(64)58(45(30)63)33-17-18-38(61)56-43(33)62/h11-16,27,29,33,41,51H,2-10,17-26,28,49H2,1H3,(H2,50,55)(H,52,59)(H,54,60)(H,56,61,62)/t29-,33?,41+/m0/s1

Standard InChI Key:  OZQFXXOAFJJFIG-QYBIWYDGSA-N

Associated Targets(Human)

PTPN11 Tchem Cereblon/Protein-tyrosine phosphatase 2C (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 945.59Molecular Weight (Monoisotopic): 944.4134AlogP: 6.06#Rotatable Bonds: 21
Polar Surface Area: 244.07Molecular Species: BASEHBA: 14HBD: 6
#RO5 Violations: 4HBA (Lipinski): 17HBD (Lipinski): 8#RO5 Violations (Lipinski): 4
CX Acidic pKa: 11.55CX Basic pKa: 9.48CX LogP: 5.25CX LogD: 3.21
Aromatic Rings: 3Heavy Atoms: 66QED Weighted: 0.05Np Likeness Score: -0.59

References

1. Yang X, Wang Z, Pei Y, Song N, Xu L, Feng B, Wang H, Luo X, Hu X, Qiu X, Feng H, Yang Y, Zhou Y, Li J, Zhou B..  (2021)  Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders.,  218  [PMID:33780898] [10.1016/j.ejmech.2021.113341]

Source